Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination therapy comprising a CDK4/6 inhibitor and a P13K inhibitor for use in the treatment of cancer

Combination therapy comprising a CDK4/6 inhibitor and a P13K inhibitor for use in the treatment of cancer

US Patent 9271988 · Granted Mar 1, 2016

Estimated economic value: $9,965,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Integrated control type hollow curtain2025
Roles of modulators of intersectin-Cdc42 signaling in Alzheimer's disease2025
High activity platinum and nickel yolk-shell catalysts2023
Direct synthesis of light olefins from carbon dioxide using yttria-stabilized zi2023
Roles of modulators of intersectin-CDC42 signaling in Alzheimer's disease2022
Antenna device2022
Antenna device2021
Method of differentiating stable angina pectoris from acute coronary syndrome an2019
Method for producing polypeptides using PDK-inactivated cells2019
Combination therapy comprising a CDK4/6 inhibitor and a PI3K inhibitor for use i2018
Combination therapy comprising a CDK4/6 inhibitor and a PI3K inhibitor for use i2018
Combination therapy comprising a CDK4/6 inhibitor and a PI3K inhibitor for use i2018